US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 20.790
  • -0.180-0.86%
Close Apr 24 16:00 ET
  • 20.790
  • 0.0000.00%
Post 16:20 ET
1.77BMarket Cap-6976P/E (TTM)

About Syndax Pharmaceuticals Company

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.

Company Profile

SymbolSNDX
Company NameSyndax Pharmaceuticals
Listing DateMar 3, 2016
Issue Price12.00
Founded2005
CEOMr. Michael A. Metzger
MarketNASDAQ
Employees184
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address35 Gatehouse Drive,Building D,3rd floor
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-419-1400
Websitehttp://www.syndax.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael A. Metzger
  • Director and Chief Executive Officer
  • 9.13M
  • Steven Closter
  • Chief Commercial Officer
  • --
  • Catherine Madigan
  • Chief Medical Officer
  • 2.81M
  • Keith A. Goldan
  • Chief Financial Officer
  • 2.83M
  • Dennis G. Podlesak
  • Chairman of the Board
  • 1.10M
  • Dr. Neil Gallagher, M.D.
  • President and Head of Research and Development
  • 3.89M
  • Dr. Briggs W. Morrison, M.D.
  • Director
  • 30.91K
  • Dr. Martin H. Huber, M.D.
  • Independent Director
  • 516.57K
  • Pierre Legault, C.P.A.,M.B.A.
  • Independent Director
  • 575.59K
  • Jennifer Ann Jarrett
  • Independent Director
  • 513.85K
  • William Meury
  • Independent Director
  • 500.27K
  • Keith A. Katkin
  • Independent Director
  • 581.02K
  • Luke J. Albrecht
  • General Counsel and Secretary
  • 2.59M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg